XENE Annual Short Term Debt
$1.30 M
+$811.00 K+166.19%
31 December 2023
Summary:
As of January 21, 2025, XENE annual short term debt is $1.30 million, with the most recent change of +$811.00 thousand (+166.19%) on December 31, 2023. During the last 3 years, it has risen by +$1.03 million (+390.19%). XENE annual short term debt is now -73.04% below its all-time high of $4.82 million, reached on December 31, 2019.XENE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE Quarterly Short Term Debt
$1.39 M
+$33.00 K+2.44%
30 September 2024
Summary:
As of January 21, 2025, XENE quarterly short term debt is $1.39 million, with the most recent change of +$33.00 thousand (+2.44%) on September 30, 2024. Over the past year, it has increased by +$33.00 thousand (+2.44%). XENE quarterly short term debt is now -91.24% below its all-time high of $15.83 million, reached on March 31, 2020.XENE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +166.2% | +2.4% |
| 3 y3 years | +390.2% | +13.4% |
| 5 y5 years | +100.0% | +13.4% |
XENE Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +166.2% | at high | |
| 5 y | 5-year | -73.0% | +390.2% | -91.2% | |
| alltime | all time | -73.0% | -91.2% |
Xenon Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.39 M(+2.4%) |
| June 2024 | - | $1.35 M(+2.3%) |
| Mar 2024 | - | $1.32 M(+1.8%) |
| Dec 2023 | $1.30 M(+166.2%) | $1.30 M(+4.3%) |
| Sept 2023 | - | $1.25 M(+1.9%) |
| June 2023 | - | $1.22 M(+2.4%) |
| Mar 2023 | - | $1.19 M(+144.7%) |
| Dec 2022 | $488.00 K(-19.3%) | $488.00 K(>+9900.0%) |
| Sept 2022 | - | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $605.00 K | $605.00 K(-11.8%) |
| Sept 2021 | - | $686.00 K(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $759.00 K(+181.1%) |
| Mar 2021 | - | $270.00 K(+1.9%) |
| Dec 2020 | $265.00 K(-94.5%) | $265.00 K(-55.5%) |
| Sept 2020 | - | $596.00 K(+0.3%) |
| June 2020 | - | $594.00 K(-96.2%) |
| Mar 2020 | - | $15.83 M(+228.6%) |
| Dec 2019 | $4.82 M(>+9900.0%) | $4.82 M(+27.7%) |
| Sept 2019 | - | $3.77 M(+42.2%) |
| June 2019 | - | $2.65 M(+356.0%) |
| Mar 2019 | - | $582.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2018 | - | $1.40 M(+100.0%) |
| Dec 2017 | $700.00 K | $700.00 K |
FAQ
- What is Xenon Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual short term debt year-on-year change?
- What is Xenon Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly short term debt year-on-year change?
What is Xenon Pharmaceuticals annual short term debt?
The current annual short term debt of XENE is $1.30 M
What is the all time high annual short term debt for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual short term debt is $4.82 M
What is Xenon Pharmaceuticals annual short term debt year-on-year change?
Over the past year, XENE annual short term debt has changed by +$811.00 K (+166.19%)
What is Xenon Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of XENE is $1.39 M
What is the all time high quarterly short term debt for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly short term debt is $15.83 M
What is Xenon Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, XENE quarterly short term debt has changed by +$33.00 K (+2.44%)